Pharmaceuticals Subscribe

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Australia

Published in ; US $ 1995 Onwards; Publisher: GlobalData

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Australia Summary GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Australia”. The report is an essential source of information on and analysis of the […]

China Human Vaccine Industry Report, 2014-2017

Published in ; US $ 2600 Onwards; Publisher: Research In China

Vaccines can prevent and control infectious diseases, so the demand for these biological products is relatively rigid. In 2013, China‚Äôs human vaccine lot release volume grew by 4.9% from a year earlier, and the market size expanded 2.8% year on […]

Argentina Pharmaceuticals and Healthcare Report Q4 2014

Published in ; US $ 1295 Onwards; Publisher: Business Monitor International

BMI View: The Argentine economy is still reeling from the January 2014 currency devaluation. Soaring inflation and stringent drug pricing controls will continue to discourage investment and erode the growth of the country’s pharmaceutical market. More foreign pharmaceutical companies will […]

Colombia Pharmaceuticals and Healthcare Report Q4 2014

Published in ; US $ 1295 Onwards; Publisher: Business Monitor International

BMI View: Revenue recorded by multinational pharmaceutical companies will continue to be constrained in Colombia over the coming years due to severe drug price cuts. Less stringent bioequivalence regulations will also undermine sale growth posted by branded generic drugmakers. However, […]

Hong Kong Pharmaceuticals and Healthcare Report Q4 2014

Published in ; US $ 1295 Onwards; Publisher: Business Monitor International

BMI View: Hong Kong will remain as an attractive destination for foreign pharmaceutical firms due to rising medical demands from the ageing population. In addition, its proximity from China will also allow companies to expand into the world’s largest emerging […]

Japan Pharmaceuticals and Healthcare Report Q4 2014

Published in ; US $ 1295 Onwards; Publisher: Business Monitor International

BMI View: The weak Japanese yen, coupled with biennial medicine price cuts, will negatively impact multinational pharmaceutical firms operating in Japan. With effect from April 1 2014, consumption tax in Japan was raised from 5% to 8% and the biennial […]

Mozambique Pharmaceuticals and Healthcare Report Q4 2014

Published in ; US $ 1295 Onwards; Publisher: Business Monitor International

BMI View: Mozambique is rich in natural resources making it a fast growing economy, both government and foreign investors are taking steps to improve the quality imported medicines and healthcare facilities. Vaccination programs and trials are being put into place, […]

Namibia Pharmaceuticals and Healthcare Report Q4 2014

Published in ; US $ 1295 Onwards; Publisher: Business Monitor International

BMI View: There are signs the Namibian government is taking the ongoing problem related to drug shortages and supply issues seriously, with the Tender Board of Namibia approving a NAD400mn spending allowance for the Ministry of Health and Social Services, […]

Netherlands Pharmaceuticals and Healthcare Report Q4 2014

Published in ; US $ 1295 Onwards; Publisher: Business Monitor International

BMI View: The contraction of the Dutch economy during the first quarter of 2014 casts doubt on the durability of its recovery. The government will continue with austerity measures to meet the terms of EU budget criteria and further restrictions […]